Moreover, HO-1 is often highly upregulated in colon cancer compared to surrounding normal tissue, suggesting that cancer cells highly expressing HO enjoy a growth advantage and provide cellular resistance against reactive oxygen species (ROS)-mediated anticancer therapies [8]–[10]. This evidence concerns the gene HMOX1 and cancer.